Large epidemiological studies of human populations have shown that significantly enhanced levels of FGF21 accompany obesity, impaired glucose tolerance, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) [2], [6], [7]. The gene discussed is FGF21; the disease is Obesity.